Markets · Explainer
Ra Capital Management Holds More VOR, Less GHRS
The VOR position grew 87.5% by share count, while the GHRS position fell 52.7% between June and September.

Kunkafa News · Published · 2 min read
By Kareem FaridDiscuss with the author on X
Key points
- Ra Capital Management reported 10,281,496 shares or units of ASND on September 30.
- The leading position accounted for 23.5% of disclosed share and fund-unit value.
- The VOR share count rose by 87.5% from June.
Ra Capital Management reported 10,281,496 shares or units of Ascendis Pharma A/S (ASND), worth $2.34bn at the end of September [1].
Source: Form 13F · September 30, 2026 · USD millions
Parabilis Medicines (PBLS) followed at $942.16m, ahead of Vaxcyte (PCVX) at $652.9m [1].
The reported Vor Biopharma (VOR) position rose from 2,402,095 shares or units in June to 4,503,882 in September, a change of 87.5% [1] [2].
The reported Gh Research (GHRS) position fell from 7,636,813 shares or units in June to 3,609,007 in September, a change of 52.7% [1] [2].
Freenome (FRNM) was the largest September position under a security identifier absent from the June table. The holding was worth $242.03m [1] [2].
The September table no longer listed the Biocryst Pharmaceuticals (BCRX) security valued at $158.27m in June [1] [2].
Form 13F records quarter-end positions. Changes in reported value reflect market prices as well as changes in the number of shares. The filing does not show trade dates or short stock positions [1].
June 30September 30
Source: Forms 13F · June 30 and September 30, 2026 · shares or fund units
| Security | June 30 units | Sept. 30 units | Sept. USD millions |
|---|---|---|---|
| ASND | 10,281,496 | 10,281,496 | 2,342.433 |
| PBLS | 28,933,371 | 29,177,964 | 942.156 |
| PCVX | 11,474,599 | 11,474,599 | 652.905 |
| RYTM | 6,666,837 | 6,666,837 | 634.783 |
| EWTX | 8,392,730 | 8,392,730 | 340.745 |
| FRNM | 0 | 15,367,270 | 242.035 |
| VOR | 2,402,095 | 4,503,882 | 85.934 |
| TSHA | 23,555,648 | 30,435,190 | 148.219 |
| GHRS | 7,636,813 | 3,609,007 | 84.739 |
| ZLAB | 5,743,533 | 2,815,543 | 74.161 |
| AMLX | 0 | 4,279,341 | 124.529 |
| BCRX | 15,827,186 | 0 | 0 |
| WVE | 26,975,505 | 0 | 0 |
Sources: Form 13F · June and September 2026.
Sources: [1] 13F-HR · 2026-11-16 · [2] 13F-HR · 2026-08-14
Kunkafa forecasts
S&P 500 Index
How far it could move, which way, by when, and how confident Kunkafa is.
Check the latest forecastsMore in Markets

CalSTRS Reports $7.88bn in NVDA
Nvidia led the share positions in the September filing at $7.88bn.

Schroder Holds More IBN, Less TPR
The IBN position grew 169.4% by share count, while the TPR position fell 55.7% between June and September.

Baillie Gifford & Co Holds More LRCX, Less SPCX
The LRCX position grew 6,028,782.8% by share count, while the SPCX position fell 24.1% between June and September.